Cyclacel’s CYC065 and Venetoclax Demonstrate Therapeutic Potential and Anticancer Activity in Acute Myeloid and Chronic Lymphocytic Leukemias

    NEXT STORY
    James E. Wagner Cultivation Corporation Expands Compassionate Care Program and Announces New Strains
    PREV STORY
    Marinus Announces Ganaxolone Orphan Epilepsy Program Updates Including Planned Clinical Program in Tuberous Sclerosis Complex
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Elixinol and KBMD Health Launch New Hemp CBD Extract

    author_avatar
    NASDAQ Market News

    Novartis receives positive CHMP opinion for Leqvio®* (inclisiran), a potential first-in-class siRNA for the treatment of high cholesterol

    author_avatar
    NASDAQ Market News

    Hemp, Inc.’s Veteran’s Village Kins Community Proves to be a Potential Safe Haven During Coronavirus Pandemic

    author_avatar
    NASDAQ Market News